Literature DB >> 8929731

Necrotizing bowel lesions complicated by Pseudomonas septicaemia in previously healthy infants.

M J Tsai1, C J Teng, R J Teng, P I Lee, M H Chang.   

Abstract

UNLABELLED: Two previously healthy infants with Pseudomonas septicaemia presented with necrotizing bowel lesions. Necrotizing bowel lesions should be suspected when infants presenting with a history of diarrhoea, develop abdominal distension and toxic signs. Pseudomonas aeruginosa should be regarded as one of the important aetiologies in such disorders, especially if there is associated neutropenia and ecthyma gangrenosum-like lesions. Antibiotics must be able to cover this pathogen to avert a catastrophic outcome.
CONCLUSION: The intestine should be considered a possible site of involvement in Pseudomonas sepsis and special attention should be paid to examination of the abdomen.

Entities:  

Mesh:

Year:  1996        PMID: 8929731     DOI: 10.1007/bf01953941

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  NECROTIZING COLITIS OF THE NEWBORN: COMMONCAUSE OF PERFORATION OF THE COLON.

Authors:  J A WALDHAUSEN; T HERENDEEN; H KING
Journal:  Surgery       Date:  1963-08       Impact factor: 3.982

2.  Serum levels of immune globulins in health and disease: a survey.

Authors:  E R Stiehm; H H Fudenberg
Journal:  Pediatrics       Date:  1966-05       Impact factor: 7.124

3.  Pseudomonas sepsis in children without previous medical problems.

Authors:  A Martín-Ancel; C Borque; F del Castillo
Journal:  Pediatr Infect Dis J       Date:  1993-03       Impact factor: 2.129

4.  Bacteremia during diarrhea: incidence, etiology, risk factors, and outcome.

Authors:  M J Struelens; M L Bennish; G Mondal; B J Wojtyniak
Journal:  Am J Epidemiol       Date:  1991-03-01       Impact factor: 4.897

5.  Pseudomonas infections in infants and children.

Authors:  L D ASAY; R KOCH
Journal:  N Engl J Med       Date:  1960-05-26       Impact factor: 91.245

6.  Pseudomonas septicemia; necrotizing bowel lesions (NEC) and skin lesions in a 5-mo-old child.

Authors:  I H Krasna; A Kurgan; S Noy
Journal:  J Pediatr Surg       Date:  1979-08       Impact factor: 2.545

Review 7.  Infections caused by Pseudomonas aeruginosa.

Authors:  G P Bodey; R Bolivar; V Fainstein; L Jadeja
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr
  7 in total
  5 in total

1.  Beneficial effect of probiotics on Pseudomonas aeruginosa-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation.

Authors:  Fu-Chen Huang; Yi-Ting Lu; Yu-Hsuan Liao
Journal:  Innate Immun       Date:  2020-09-28       Impact factor: 2.680

2.  Pseudomonas aeruginosa expresses a lethal virulence determinant, the PA-I lectin/adhesin, in the intestinal tract of a stressed host: the role of epithelia cell contact and molecules of the Quorum Sensing Signaling System.

Authors:  Licheng Wu; Christopher Holbrook; Olga Zaborina; Emelia Ploplys; Flavio Rocha; Daniel Pelham; Eugene Chang; Mark Musch; John Alverdy
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

3.  Shanghai fever, a fatal enteric illness, in an adult patient with neutropenia caused by treatment-related myelodysplastic syndrome: a case report.

Authors:  Taichi Horino; Tatsunori Miyata; Mitsuhiro Inoue; Kosuke Ono; Asuka Ono; Yoshiyuki Tagayasu; Daichi Nomoto; Takao Mizumoto; Tatsuo Kubota; Nobutomo Miyanari; Hideo Baba
Journal:  Surg Case Rep       Date:  2022-04-18

4.  Diversity of Antimicrobial Resistance and Virulence Determinants in Pseudomonas aeruginosa Associated with Fresh Vegetables.

Authors:  Kashina Allydice-Francis; Paul D Brown
Journal:  Int J Microbiol       Date:  2012-11-20

5.  Shanghai fever: a distinct Pseudomonas aeruginosa enteric disease.

Authors:  Chih-Hsien Chuang; Yi-Hsin Wang; Hsin-Ju Chang; Hsiu-Ling Chen; Yhu-Chering Huang; Tzou-Yien Lin; Egon A Ozer; Jonathan P Allen; Alan R Hauser; Cheng-Hsun Chiu
Journal:  Gut       Date:  2013-08-13       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.